Next, we designed a composite nomogram with REPIN1, PSD3, RDX, CDK4, FANCI, and ARHGEF9 to predict 1-, 3-, and 5-year OS in glioma patients (Figure 3(d)). This evidence concerns the gene ARHGEF9 and glioma.